康龙化成,300759,收入构成,报告日期,2019-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),956,385,571,59.76%,1.09% 实验室服务,105986,66273,39712,37.47%,75.67% CMC,37689,29879,7809,20.72%,14.88% 临床研究服务,19021,14635,4387,23.06%,8.36% 康龙化成,300759,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 临床研究服务,34750,25948,8803,25.33%,9.32% CMC,64582,50520,14063,21.78%,14.89% 其他(补充),1904,899,1005,52.81%,1.06% 实验室服务,189575,118980,70596,37.24%,74.73% 康龙化成,300759,收入构成,报告日期,2018-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 药物发现与研究,128245,78074,50171,39.12%,77.48% 其他(补充),1496,701,795,53.12%,1.23% 药物开发与生产,73809,60024,13786,18.68%,21.29% 康龙化成,300759,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 药物开发与生产,46205,39221,6983,15.11%,18.28% 药物发现与研究,79880,49212,30669,38.39%,80.28% 其他(补充),972,423,549,56.5%,1.44% 康龙化成,300759,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 药物开发与生产,88281,72782,15499,17.56%,20.64% 其他(补充),1618,665,953,58.9%,1.27% 药物发现与研究,139513,80864,58650,42.04%,78.09% 康龙化成,300759,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 药物发现与研究,106910,68586,38324,35.85%,80.86% 药物开发与生产,56510,47436,9073,16.06%,19.14% 其他(补充),4,-- ,-- ,--,0% 康龙化成,300759,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),103,97,6,6.06%,0.02% 药物发现与研究,78165,56586,21579,27.61%,69.52% 药物开发与生产,34536,25081,9454,27.38%,30.46%